Xinchang County, Taiwan

Yongmei Xu

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongmei Xu. Retrieved from https://idiyas.com/inventor/yongmei-xu-pd7zims3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yongmei Xu: Innovator in Anticancer Pharmaceuticals

Introduction

Yongmei Xu is a prominent inventor based in Xinchang County, Taiwan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compounds. Her innovative work has the potential to impact cancer treatment positively.

Latest Patents

Yongmei Xu holds a patent for a compound titled "2, 6-Di-nitrogen-containing substituted purine derivative, and preparation method, pharmaceutical composition and use thereof." This invention provides a 2, 6-di-nitrogen-containing substituted purine derivative, which is characterized by its broad-spectrum anticancer properties, low toxicity, high anticancer activity, and good stability. The compound's formula (I) structure offers a promising avenue for future pharmaceutical applications.

Career Highlights

Yongmei Xu is currently employed at Zhejiang Medicine Co., Ltd., specifically at the Xinchang Pharmaceutical Factory. Her role in this organization allows her to further her research and development efforts in the pharmaceutical industry.

Collaborations

Yongmei collaborates with notable colleagues, including Guofeng Wu and Wei Mao, who contribute to her research endeavors and enhance the innovative environment at her workplace.

Conclusion

Yongmei Xu's work in developing anticancer pharmaceuticals showcases her dedication to advancing medical science. Her innovative patent reflects her commitment to improving cancer treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…